Blu reported numbers look weak, with revenue down 7%, EBITDA swinging to a R4.77bn loss, and headline earnings down 82% to R756m. But these numbers are heavily distorted by the Cell C restructuring/listing accounting effects. On a normalised basis, revenue was R9.44bn, EBITDA R923m, net profit R677m, and core headline earnings R681m / 75.33c per share. BLU resumed dividend payments with a 53.56c total dividend for FY2026, comprising the 43.56c interim and 10c final dividend.
Click here to read the SENS